Table 2. Prevention of Dysbiosis.
| Intervention | Mechanism of action/Application | Advantages | Disadvantages | References |
| Control measures | -Screening via nasal or rectal swabs for multidrug-resistant
organisms. -Good hygiene, environmental cleaning, contact precautions etc. |
-Easy to apply. | -Difficult to measure its direct effectiveness. | [103,128-130] |
| Antimicrobial stewardship programs | -Wise choice of antibiotics (e.g. avoidance of anti-anaerobic
antimicrobials) and use of narrow-spectrum agents help to preserve gut
microbiota. -Shorter courses of antibiotics lead to fewer microbiota disruptions and easier restoration. -Lower doses of antibiotics result in a lower risk of resistant genes. -Use of antibiotics that are not faecally and/or biliary excreted prevents the development of gut resistance. |
-Good rates of preventing infections with multidrug-resistant
organisms. -Applicable in every healthcare facility. -No need for adjuvant equipment/substances. |
-No many directly focused studies on the colonization of the gut
microbiota. -In some cases, it is inevitable to avoid some antibiotics. -Needs coordinated action between many specialties. |
[102,103,129,131,136,137,139,140,143,144] |
| Chelating/degradating agents | -Use of substances such as beta-lactamase enzymes and charcoal-based substances that absorb the remaining amount of antibiotic before reaching the colon protecting this way the gut microbiota without affecting the serum levels of the antibiotic. | -Promising preliminary results. -No serious adverse events. |
-Need for more clinical trials. -Difficult to measure their long-term clinical benefit. |
[102,145,147,150-153,156,158,159,161,163] |